HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late-onset distal muscular dystrophy affecting the posterior calves.

Abstract
Miyoshi myopathy, caused by mutations in the membrane protein dysferlin, is the most common muscular dystrophy that presents in the posterior calves. Its onset is before the age of 30 years and it is associated with marked elevations of serum creatine kinase (CK). In contrast, little is known about calf myopathies with onset after the age of 30, and it is not clear whether such patients have a dysferlinopathy. We describe five patients with a myopathy predominantly affecting the calf muscles, with onset after the age of 30. Muscle tissue was analyzed by immunoblot for dystrophin and dysferlin. All five had normal dysferlin but one had a dystrophinopathy. Serum CK levels ranged from 3 to 15 times the upper limit of normal. In contrast, all of 13 patients presenting before age 30 with calf weakness had a dysferlinopathy. Thus, isolated calf atrophy and weakness with onset after age 30, and associated with serum CK levels that are only moderately elevated, represents a distinct myopathy phenotype. Most of these cases are sporadic, although the overall phenotype appears genetically heterogeneous and dysferlinopathy is uncommon.
AuthorsJonathan S Katz, Thomas A Rando, Richard J Barohn, David S Saperstein, Carlayne E Jackson, Matthew Wicklund, Anthony A Amato
JournalMuscle & nerve (Muscle Nerve) Vol. 28 Issue 4 Pg. 443-8 (Oct 2003) ISSN: 0148-639X [Print] United States
PMID14506716 (Publication Type: Journal Article)
Chemical References
  • DYSF protein, human
  • Dysferlin
  • Dystrophin
  • Membrane Proteins
  • Muscle Proteins
  • Creatine Kinase
Topics
  • Adult
  • Age of Onset
  • Creatine Kinase (blood)
  • Dysferlin
  • Dystrophin (metabolism)
  • Humans
  • Leg
  • Magnetic Resonance Imaging
  • Membrane Proteins
  • Middle Aged
  • Muscle Proteins (metabolism)
  • Muscle, Skeletal (metabolism, pathology)
  • Muscular Dystrophies (diagnosis, epidemiology, metabolism, pathology)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: